Wenchuan Li
No. 18 Zhongshan Road
Baise City, 533000, China
Baise City, 533000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Retraction notice to "PAARH promotes M2 macrophage polarization and immune evasion of liver cancer cells through VEGF protein" [Int. J. Biol. Macromol. 281 (2024) 136580].
Journal: International journal of biological macromolecules
Published: July 21, 2026
PAARH suppresses Kupffer cell phagocytosis to promote tumor liver metastasis by upregulating CD47.
Journal: Cancer cell international
Published: July 21, 2025
PAARH promotes M2 macrophage polarization and immune evasion of liver cancer cells through VEGF protein.
Journal: International journal of biological macromolecules
Published: August 29, 2024
m6A-Methylated NUTM2B-AS1 Promotes Hepatocellular Carcinoma Stemness Feature via Epigenetically Activating BMPR1A Transcription.
Journal: Journal of hepatocellular carcinoma
Published: July 18, 2024
Peptide CCAT1-70aa promotes hepatocellular carcinoma proliferation and invasion via the MAPK/ERK pathway.
Journal: Open medicine (Warsaw, Poland)
Published: June 04, 2024
LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: November 09, 2023
METTL3 and METTL14-mediated N6-methyladenosine modification of SREBF2-AS1 facilitates hepatocellular carcinoma progression and sorafenib resistance through DNA demethylation of SREBF2.
Journal: Scientific reports
Published: November 06, 2023
METTL3/16-mediated m6A modification of ZNNT1 promotes hepatocellular carcinoma progression by activating ZNNT1/osteopontin/S100A9 positive feedback loop-mediated crosstalk between macrophages and tumour cells.
Journal: Clinical immunology (Orlando, Fla.)
Published: September 06, 2023
N6-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/β-Catenin Signaling.
Journal: Journal of hepatocellular carcinoma
Published: July 30, 2023
HIF‑1α and RACGAP1 promote the progression of hepatocellular carcinoma in a mutually regulatory way.
HIF‑1α and RACGAP1 promote the progression of hepatocellular carcinoma in a mutually regulatory way.
Journal: Molecular medicine reports
Published: May 09, 2023
Hypoxia-induced HIF1A activates DUSP18-mediated MAPK14 dephosphorylation to promote hepatocellular carcinoma cell migration and invasion.
Journal: Pathology, research and practice
Published: November 07, 2021
Last Updated: 09/26/2026